Clinical trials: Radiation Oncology
Cancer, Neoplasm Metastasis
ECI301 and Radiation for Advanced or Metastatic Cancer
Background: ECI301 is a drug that may help make cancer cells more visible to the immune system after radiation. The drug may also help the immune system destroy the cancer at sites that have not received radiation therapy.
- Conditions
- Cancer, Neoplasm Metastasis, Radiation Oncology, Neoplasm
- Trial name
- NCT01441115
- Testing
- Radiation Therapy, ECI301
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- National Cancer Institute (NCI)